Putative Telomere-Recruiting Domain in the Catalytic Subunit of Human Telomerase

REFERENCES

• Armbruster, B. N., S. S. Banik, C. Guo, A. C. Smith, and C. M. Counter. 2001. N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol. Cell. Biol. 21: 7775–7786.
   PubMed Web of Science ®Google Scholar
• Baumann, P., and T. R. Cech. 2001. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292: 1171–1175.
   PubMed Web of Science ®Google Scholar
• Blackburn, E. H. 2001. Switching and signaling at the telomere. Cell 106: 661–673.
   PubMed Web of Science ®Google Scholar
• Broccoli, D., A. Smogorzewska, L. Chong, and T. de Lange. 1997. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17: 231–235.
   PubMed Web of Science ®Google Scholar
• Chong, L., B. van Steensel, D. Broccoli, H. Erdjument-Bromage, J. Hanish, P. Tempst, and T. de Lange. 1995. A human telomeric protein. Science 270: 1663–1667.
   PubMed Web of Science ®Google Scholar
• Counter, C. M., W. C. Hahn, W. Wei, S. D. Caddle, R. L. Beijersbergen, P. M. Lansdorp, J. M. Sedivy, and R. A. Weinberg. 1998. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95: 14723–14728.
   PubMed Web of Science ®Google Scholar
• Etheridge, K. T., S. S. Banik, B. N. Armbruster, Y. Zhu, R. M. Terns, M. P. Terns, and C. M. Counter. 2002. The nucleolar localization domain of the catalytic subunit of human telomerase. J. Biol. Chem. 277: 24764–24770.
   PubMed Web of Science ®Google Scholar
• Evans, S. K., and V. Lundblad. 1999. Est1 and Cdc13 as comediators of telomerase access. Science 286: 117–120.
   PubMedGoogle Scholar
• Evans, S. K., and V. Lundblad. 2000. Positive and negative regulation of telomerase access to the telomere. J. Cell Sci. 113: 3357–3364.
   PubMedGoogle Scholar
• Fairall, L., L. Chapman, H. Moss, T. de Lange, and D. Rhodes. 2001. Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Mol. Cell 8: 351–361.
   PubMed Web of Science ®Google Scholar
• Friedman, K. L., and T. R. Cech. 1999. Essential functions of amino-terminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants. Genes Dev. 13: 2863–2874.
   PubMedGoogle Scholar
• Griffith, J. D., L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi, H. Moss, and T. de Lange. 1999. Mammalian telomeres end in a large duplex loop. Cell 97: 503–514.
   PubMed Web of Science ®Google Scholar
• Guo, C., D. Geverd, R. Liao, N. Hamad, C. M. Counter, and D. T. Price. 2001. Inhibition of telomerase is related to the lifespan and tumorigenicity of human prostate cancer cells. J. Urol. 166: 694–698.
   PubMedGoogle Scholar
• Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464–468.
   PubMed Web of Science ®Google Scholar
• Hahn, W. C., S. A. Stewart, M. W. Brooks, S. G. York, E. Eaton, A. Kurachi, R. L. Beijersbergen, J. H. Knoll, M. Meyerson, and R. A. Weinberg. 1999. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5: 1164–1170.
   PubMed Web of Science ®Google Scholar
• Holt, S. E., W. E. Wright, and J. W. Shay. 1996. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16: 2932–2939.
   PubMed Web of Science ®Google Scholar
• Karlseder, J., D. Broccoli, Y. Dai, S. Hardy, and T. de Lange. 1999. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321–1325.
   PubMed Web of Science ®Google Scholar
• Kim, N. W., and F. Wu. 1997. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25: 2595–2597.
   PubMed Web of Science ®Google Scholar
• Lendvay, T. S., D. K. Morris, J. Sah, B. Balasubramanian, and V. Lundblad. 1996. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144: 1399–1412.
   PubMed Web of Science ®Google Scholar
• Lingner, J., T. R. Cech, T. R. Hughes, and V. Lundblad. 1997. Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc. Natl. Acad. Sci. USA 94: 11190–11195.
   PubMedGoogle Scholar
• Lundblad, V., and J. W. Szostak. 1989. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633–643.
   PubMed Web of Science ®Google Scholar
• Murnane, J. P., L. Sabatier, B. A. Marder, and W. F. Morgan. 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13: 4953–4962.
   PubMed Web of Science ®Google Scholar
• Nakamura, T. M., and T. R. Cech. 1998. Reversing time: origin of telomerase. Cell 92: 587–590.
   PubMed Web of Science ®Google Scholar
• Ouellette, M. M., D. L. Aisner, I. Savre-Train, W. E. Wright, and J. W. Shay. 1999. Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Commun. 254: 795–803.
   PubMed Web of Science ®Google Scholar
• Sedivy, J. M. 1998. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc. Natl. Acad. Sci. USA 95: 9078–9081.
   PubMedGoogle Scholar
• Seimiya, H., H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko, K. Yamane, and T. Tsuruo. 2000. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 19: 2652–2661.
   PubMed Web of Science ®Google Scholar
• Shay, J. W., and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33: 787–791.
   PubMed Web of Science ®Google Scholar
• Stewart, N., and S. Bacchetti. 1991. Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 180: 49–57.
   PubMedGoogle Scholar
• van Steensel, B., and T. de Lange. 1997. Control of telomere length by the human telomeric protein TRF1. Nature 385: 740–743.
   PubMed Web of Science ®Google Scholar
• van Steensel, B., A. Smogorzewska, and T. de Lange. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401–413.
   PubMed Web of Science ®Google Scholar
• Weinrich, S. L., R. Pruzan, L. Ma, M. Ouellette, V. M. Tesmer, S. E. Holt, A. G. Bodnar, S. Lichtsteiner, N. W. Kim, J. B. Trager, R. D. Taylor, R. Carlos, W. H. Andrews, W. E. Wright, J. W. Shay, C. B. Harley, and G. B. Morin. 1997. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17: 498–503.
   PubMed Web of Science ®Google Scholar
• Wright, W. E., V. M. Tesmer, M. L. Liao, and J. W. Shay. 1999. Normal human telomeres are not late replicating. Exp. Cell Res. 251: 492–499.
   PubMed Web of Science ®Google Scholar
• Xia, J., Y. Peng, I. S. Mian, and N. F. Lue. 2000. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol. Cell. Biol. 20: 5196–5207.
   PubMed Web of Science ®Google Scholar
• Zhu, J., H. Wang, J. M. Bishop, and E. H. Blackburn. 1999. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96: 3723–3728.
   PubMed Web of Science ®Google Scholar